These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34949658)

  • 21. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
    Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():835914. PubMed ID: 35991009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of CIAPIN1 (Cytokine-Induced Apoptosis Inhibitor 1) Signaling Pathway and Its Role in Cholangiocarcinoma Metastasis.
    Truong SDA; Wongwattanakul M; Proungvitaya T; Limpaiboon T; Roytrakul S; Chua-On D; Tummanatsakun D; Proungvitaya S
    J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.
    Kotepui KU; Obchoei S; Vaeteewoottacharn K; Okada S; Wongkham S; Sawanyawisuth K
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):715-721. PubMed ID: 35225485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.
    Pan S; Hu Y; Gan L; Lai J; Zheng P; Zhang Y; Shuai L; Jiang Y; Chen M; Wang J; He Y
    Ann Hepatol; 2024; 29(2):101279. PubMed ID: 38123132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation.
    Wang Z; Wu S; Wang G; Yang Z; Zhang Y; Zhu C; Qin X
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676763
    [No Abstract]   [Full Text] [Related]  

  • 29. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
    Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H
    Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatic Prediction of Signaling Pathways for Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) and Its Role in Cholangiocarcinoma Cells.
    Tummanatsakun D; Proungvitaya T; Roytrakul S; Proungvitaya S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of mucinous cholangiocarcinoma with lymph node metastasis].
    Gotoh K; Nagano H; Sakon M; Miyamoto A; Shimizu J; Taniguchi H; Dono K; Nakamori S; Umeshita K; Gotoh M; Nakamura H; Wakasa K; Monden M
    Nihon Shokakibyo Gakkai Zasshi; 1999 Dec; 96(12):1401-6. PubMed ID: 10643307
    [No Abstract]   [Full Text] [Related]  

  • 33. CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
    Yamamoto Y; Sugimoto A; Maruo K; Tsujio G; Sera T; Kushiyama S; Nishimura S; Kuroda K; Togano S; Eguchi S; Tanaka R; Kimura K; Amano R; Ohira M; Yashiro M
    PLoS One; 2022; 17(4):e0266027. PubMed ID: 35377900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
    Namwat N; Puetkasichonpasutha J; Loilome W; Yongvanit P; Techasen A; Puapairoj A; Sripa B; Tassaneeyakul W; Khuntikeo N; Wongkham S
    J Gastroenterol; 2011 May; 46(5):664-75. PubMed ID: 21076843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.
    Watanabe A; Suzuki H; Yokobori T; Altan B; Kubo N; Araki K; Wada S; Mochida Y; Sasaki S; Kashiwabara K; Hosouchi Y; Kuwano H
    Cancer Sci; 2013 Nov; 104(11):1427-32. PubMed ID: 23919841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 promotes migration and invasion of cholangiocarcinoma arising from choledochal cyst by transcriptionally inhibiting miR200c through the c-myb/MEK/ERK signaling pathway.
    Liu W; Fan L; Shao B; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):136-142. PubMed ID: 37807322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma.
    Liu Y; Liu X; Zhou Y; Liu T; Li J
    Clin Exp Med; 2021 Feb; 21(1):121-128. PubMed ID: 32816152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph node metastasis in intrahepatic cholangiocarcinoma.
    Yamamoto M; Takasaki K; Yoshikawa T
    Jpn J Clin Oncol; 1999 Mar; 29(3):147-50. PubMed ID: 10225697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.